Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1455, 2004-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Galantamine treatment for AD warranted in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 339, 2001-01 ,pp. :
Access to resources
Recommend
Galantamine beneficial in mild-to-moderate AD
Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. :
Olanzapine worth it for agitation, psychosis in AD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 553, 2008-01 ,pp. :